Eurydice A.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Palazestrant and Ribociclib versus Letrozole and Ribociclib for First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Evaluation of Gene Expression-Driven Adjuvant Chemotherapy Versus Standard Care in Premenopausal HR-Positive/HER2-Negative Breast Cancer Using Paclitaxel and Drug Combination
- Efficacy and Safety of RLY-2608 Plus Fulvestrant Versus Capivasertib Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer
Data & Insights
Has run more than one trial at 96 of 310 partner sites.
Specializations
Medical Oncology and Solid Tumors
The investigator is active in medical oncology with a strong focus on advanced solid tumors, including non-small cell lung cancer, breast cancer, colorectal cancer, gastric cancer, hepatocellular carcinoma, biliary tract cancer, and urothelial carcinoma.
- Non-small cell lung cancer
- Breast cancer
- Hepatocellular carcinoma
- Colorectal cancer
- Urothelial carcinoma
Research interest also extends to melanoma, head and neck cancer, ovarian cancer, pancreatic cancer, and other metastatic malignancies requiring innovative systemic treatment strategies.
Hematologic Malignancies and Cellular Therapy
Clinical work includes acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms.
- Acute myeloid leukemia
- Myelodysplastic syndromes
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Multiple myeloma
Therapeutic involvement also covers relapsed and refractory blood cancers, molecularly defined leukemia, and transplant-related hematology, supporting the development of newer targeted and immune-based approaches.
Autoimmune and Inflammatory Diseases
The investigator is involved in trials addressing systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, Sjögren’s disease, and vasculitis.
- Systemic lupus erythematosus
- Lupus nephritis
- Rheumatoid arthritis
- Systemic sclerosis
- ANCA-associated vasculitis
Additional interests include myositis, immune thrombocytopenia, sarcoidosis, inflammatory bowel disease, and eosinophilic disorders, reflecting a broad therapeutic portfolio in immune-mediated conditions.
Pulmonary, Infectious, and Critical Care Conditions
Research activity also spans idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, pulmonary sarcoidosis, chronic obstructive pulmonary disease, and community-acquired pneumonia.
- Idiopathic pulmonary fibrosis
- Interstitial lung disease
- Pulmonary sarcoidosis
- Community-acquired pneumonia
- Sepsis
Further involvement includes mycobacterial lung infection, viral hepatitis, HIV infection, mpox, and intensive care syndromes such as acute respiratory distress syndrome and septic shock.
Cardiometabolic, Renal, and Rare Disease Interests
The investigator’s portfolio includes atherosclerotic cardiovascular disease, myocardial infarction, heart failure, hypertension, pulmonary hypertension, and cardiogenic shock.
- Atherosclerotic cardiovascular disease
- Heart failure
- Chronic kidney disease
- IgA nephropathy
- Transthyretin amyloidosis
Additional therapeutic interests include kidney transplant rejection, proteinuric kidney disease, diabetes, obesity, amyloidosis, and selected rare genetic disorders such as alport syndrome and familial Mediterranean fever.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.